Controversy over the benefits of statins may have led patients to abandon their use, endangering their health, it was claimed today.
Professor Liam Smeeth of the London School of Hygiene & Tropical Medicine, UK, and colleagues looked into the impact of the controversy over the risks and benefits of statins, which was widely reported.
They analysed prescribing figures from UK primary care records, focusing on people aged at least 40 who started or stopped statins each month from January 2011 to March 2015.
This showed that many heart disease patients stopped taking statins, in addition to those at high risk of developing heart disease in the next ten years. Older people, and those who had been taking statins for a longer period of time, were more likely to stop.
Controversy did not appear to affect newly eligible patients who were prescribed statins for the first time, the researchers found.
The controversy erupted in the BMJ in October 2013 when it was claimed the drugs were about to be prescribed to people who would get little benefit from them.
In today’s (29 June) BMJ the researchers say that more than 200,000 UK patients may have stopped statin therapy in the six months after the media coverage. They fear that this could lead to more than 2,000 extra cardiovascular events if continued over the next decade.
Professor Smeeth said: "Journalists are faced with the difficult task of reporting claims and counter claims when it comes to health research. While they are accountable for accurate, balanced and responsible reporting, scientists, journals and press offices are accountable for the accurate dissemination of research."
Commenting on the study in an editorial in the same journal, Gary Schwitzer, publisher of HealthNewsReview.org, says the study authors "assumed causality but did not prove it".
He adds: "We know nothing about why these patients stopped. The debate over the harms and benefits of statins is not over. Journals, journalists, clinicians, and researchers could help people to grasp the uncertainty that still exists and to attack it by asking more questions."
The UK Royal College of GPs called on patients not to make "unilateral" decisions following media reports – but to discuss concerns with their doctor.
Chair Dr Maureen Baker said: “Prescribing statins will not be a decision taken lightly, and it is important that patients who are prescribed them undertake regular medication reviews, and that they use this opportunity to raise any concerns they may have.”
Matthews, A. et al. Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data. BMJ 29 June 2016; doi: 10.1136/bmj.i3283 [abstract]

Leave a Reply